Company intelligence / Profile preview

Paras Biopharmaceuticals Finland Oy

Oulu, Northern Ostrobothnia, Finlandparasbiopharma.com ↗

Ownership: Private
Development stage: Commercial

Overview

Paras Biopharmaceuticals Finland Oy operates as a technology-driven CDMO specializing in microbial expression systems for recombinant proteins, therapeutic peptides, and biosimilars. The company has developed proprietary platforms that enable high-yield production of complex biologics. Its pipeline includes several biosimilars targeting autoimmune diseases, rare blood disorders like ITP, osteoporosis, oncology/immunology areas, with some assets available for outlicensing or co-development. The company’s focus remains on process innovation and cost-effective manufacturing rather than direct clinical commercialization.

Therapeutic areas: OncologyEndocrinologyRheumatologyMen's Health
Modalities: Recombinant proteinsTherapeutic peptidesBiosimilars (including mAbs and peptide-based biologics)Enzymes for medicinal and bioprocess purposesFC-fusion proteins
Industry: Contract Manufacturing Organization

Drug pipeline

4 assets

teriparatide

Development

Indications: Osteoporosis

3 more assets in the full pipeline.

Request access →

Partnerships

Multiple US & European clientsopen to co-development/licensing partnerships with global biopharma companiescollaborations with world-leading labs on product development projects.

Beyond the preview

Go deeper on Paras Biopharmaceuticals Finland Oy.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Paras Biopharmaceuticals Finland Oy.

Explore the full profile